Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: J Matern Fetal Neonatal Med. 2010 Feb;23(2):167–178. doi: 10.3109/14767050903067378

Figure 2.

Figure 2

Plasma concentrations of sVEGFR-2 in normal pregnant women, pregnant women with acute pyelonephritis, and patients with preeclampsia. Pregnant women with acute pyelonephritis and patients with preeclampsia had median plasma concentrations of sVEGFR-2 lower than normal pregnant women (normal pregnancy: median 12.9 ng/ml, IQR 10.1-15.7 ng/ml; acute pyelonephritis: median 8.7 ng/ml, IQR 6.9-10.3 ng/ml; preeclampsia: median 7.6 ng/ml, IQR 6.6-10.6 ng/ml; both p<0.001). There was no significant difference in the median plasma concentrations of sVEGFR-2 between patients with preeclampsia and those with acute pyelonephritis (p=0.5). *:p<0.05.